Caricamento...
Comparing Oncology Clinical Programs by Use of Innovative Designs and Expected Net Present Value Optimization: Which Adaptive Approach Leads to the Best Result?
Designing an oncology clinical program is more challenging than designing a single study. The standard approaches have been proven to be not very successful during the last decade; the failure rate of Phase 2 and Phase 3 trials in oncology remains high. Improving a development strategy by applying i...
Salvato in:
| Pubblicato in: | J Biopharm Stat |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5383527/ https://ncbi.nlm.nih.gov/pubmed/28281911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2017.1289949 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|